Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced hypertension

Regulatory Peptides

Volumn 146, Issue 1-3, 2008, Pages 38-45

  Mayer, Marcos A ^a   Höcht, Christian ^a   Gironacci, Mariela ^a   Opezzo, Javier A W ^a   Taira, Carlos A ^a   Fernández, Belisario E ^a   Puyó, Ana M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Angiotensin; Anterior hypothalamic area; Fructose; Hypertension; Noradrenaline; Reverse microdialysis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; FRUCTOSE; IRBESARTAN; METOPROLOL; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART RATE; HYPOTHALAMUS; INSULIN RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MICRODIALYSIS; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; FRUCTOSE; HYPERTENSION; HYPOTHALAMUS; INSULIN RESISTANCE; MALE; METOPROLOL; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

ANIMALIA; RATTUS;

EID: 38149081292     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.07.006     Document Type: Article

References (32)

1. Mancia G., Dell'Oro R., Quarti-Trevano F., Scopelliti F., and Grassi G. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease. J Hypertens 24 Suppl 1 (2006) S51-S56
2. Grassi G. Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. J Hypertens 19 (2001) 1713-1716
3. Taddei S., and Grassi G. Angiotensin II as the link between nitric oxide and neuroadrenergic function. J Hypertens 23 (2005) 935-937
4. Dzimiri N. Receptor crosstalk. Implications for cardiovascular function, disease and therapy. Eur J Biochem 269 (2002) 4713-4730
5. Höcht C., Opezzo J.A.W., Gironacci M.M., Peña C., and Taira C.A. Anterior hypothalamic β-adrenoceptors in chronic aortic coarctated hypertensive rats. An interaction with central Angiotensin II receptors. Clin Exp Pharmacol Physiol 32 (2005) 30-34
6. Mancia G., Bousquet P., Elghozi J.L., Ester M., Grassi G., Julius S., Reid J., and Van Zwieten P.A. The sympathetic nervous system and the metabolic syndrome. J Hypertens 25 (2007) 909-920
7. Muntzel M.S., Joseph T., and Onwumere O. Effect of insulin-induced hypokalemia on lumbar sympathetic nerve activity in anesthetized rats. J Hypertens 22 (2004) 1755-1760
8. Hwang I.S., Ho H., Hoffmann B., and Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10 (1987) 512-516
9. Catena C., Giacchetti G., Novello M., Colussi G., Cavarape A., and Sechi L.A. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens 16 (2003) 973-978
10. Hsieh P.S. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats. J Hypertens 23 (2005) 2209-2217
11. Okada K., Hirano T., Ran J., and Adachi M. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. Hypertens Res 27 (2004) 293-299
12. Verma S., Bhanot S., and McNeill J.H. Sympathectomy prevents fructose induced hyperinsulinemia and hypertension. Eur J Pharmacol 373 (1999) R1-R4
13. Mayer M.A., Höcht C., Opezzo J.A.W., Peredo H.A., Navacchia D., Taira C.A., et al. Role of hypothalamic alpha-2 adrenergic activity in fructose induced hypertension. Clin Exp Pharmacol Physiol 33 (2006) 904-909
14. NRC (National Research Council). Guide for the care and use of laboratory animals. A report of the institute of laboratory animal resource committee on the care and use of laboratory animals. NIH publication vol. 85-23 (1985), US Department of Health and Human Services, Washington, DC
15. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic Press, New York
16. Mayer M.A., Höcht C., Opezzo J.A.W., Taira C.A., Fernández B.E., and Puyó A.M. High fructose diet increases anterior hypothalamic alpha 2-adrenoceptor responsiveness. Neurosci Lett 423 (2007) 128-132
17. Claassen V. Anaesthesia. Neglected factors in pharmacology and neuroscience research (1994), Amsterdam, Elsevier 382-421 chapter 16
18. Bourne J.A. Intracerebral microdialysis: 30 years as a tool for the neuroscientist. Clin Exp Pharmacol Physiol 30 (2003) 16-24
19. Wong P.S.K., and Johns E.J. Effect of acute saline volume loading on renal sympathetic nerve activity in anaesthetised fructose-fed and fat-fed rats. J Auton Nerv Syst 75 (1999) 60-69
20. Höcht C., Opezzo J.A., and Taira C.A. Applicability of reverse microdialysis in pharmacological and toxicological studies. J Pharmacol Toxicol Methods 55 (2007) 3-15
21. Ran J., Hirano T., Fukui T., Saito K., Kageyama H., Okada K., and Adachi M. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metab Clin Exp 55 (2006) 478-488
22. Ogihara T., Asano T., Ando K., et al. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40 (2002) 872-879
23. Nickenig G., Roling J., Strehlow K., et al. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 22 (1998) 2453-2460
24. Giacchetti G., Sechi L., Griffin C., Don B., Mantero F., and Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens 18 (2000) 695-702
25. Hsieh P.S. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats. J Hypertens 23 (2005) 2209-2217
26. Kamide K., Rakugi H., Higaki J., Okamura A., Nagai M., Moriguchi K., Ohishi M., Satoh N., Tuck M., and Ogihara T. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 15 (2002) 66-71
27. Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., and Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43 (2004) 255-262
28. Gelband C.H., Sumners C., Lu D., and Raizada M.K. Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul Pept 72 (1997) 139-145
29. Kubo T., Yamaguchi H., Tsujimura M., Hagiwara Y., and Fukumori R. An angiotensin system in the anterior hypothalamic area anterior is involved in the maintenance of hypertension in spontaneously hypertensive rats. Brain Res Bull 52 4 (2000) 291-296
30. Kubo T., and Hagiwara Y. Evidence suggesting that angiotensins released not via synaptic inputs are involved in the basal activity of anterior hypothalamic neurons in rats. Neurosci Lett 400 (2006) 92-96
31. De Wardener H.E. The hypothalamus and hypertension. Physiol Rev 81 (2001) 1599-1658
32. Murugaiah K.D., and O'Donnell J.M. Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 351 5 (1995) 483-490